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ABSTRACT 
An eco-friendly synthesis of pyrano[3,2-c]chromen-5(4H)-one 
derivatives was conducted by the condensation of 4-hydroxycoumar-
ins, aromatic aldehydes, and acetophenones. Clean profile, excellent 
yield, ambient temperature, and use of visible light intensity instead of 
catalyst are the attractive features of this method.  
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Introduction 
Unique chemical,[1] biological,[2] and physical properties[3] associated with pyran derivatives 
have found broad applications as agrochemical and drugs. Pyran derivatives are widespread 
in nature. They are core skeletons in numerous natural products such as Frutinone A and 
Frutinone C (Polygala fruticosa) and Isoethulia-coumarin C (Ethulia conyzoides)[4] (Fig. 1). 
The presence of pyran architectures in nature with antimicrobial,[5] anticancer,[6] 
antidyslipidemic,[7] antihyperglycemic,[8] anti-HIV,[9] antioxidant,[10] antiallergic,[11] xan-
thine oxidase inhibitory,[12] acetylcholinesterase, and butyrylcholinesterase inhibitory,[13] 
Src kinase inhibitory activities[14] made it a privileged structure. 
Extensive research efforts have been focused on development of various strategies-
[15,16] for the synthesizing pyran derivatives. Few general methods are (i) one-pot 
condensation of aromatic aldehydes, malanonitrile/ethylcyanoacetate, and α-hydroxy 
C–H acids[17] (ii) four-component reactions of arylamine, acetylenedicarboxylate, 
aromatic aldehydes, and cyclic 1,3-diketones[18] (iii) intramolecular alkoxycarbonylative 
annulation[19] (iv) one-pot synthesis of pyran-based heterocycles from benzyl halides as 
key reagents.[20] Even though synthesis of pyran derivatives using variety of catalysts such 
as ZnFe2O4,[21] cellulose–perchloric acid,[22] meglumine,[23] gold(III),[24] nickel 
none defined  
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nanoparticles,[25] DBU,[26] Fe(HSO4)3,[27] Ce(SO4)2.4H2O,[28] and ionic liquid[29] have 
made tremendous progress in the past years, this reaction still has limitations including 
nongeneralization, use of excess amount of expensive catalysts, harsh reaction condition, 
low yields, and long reaction time. Therefore, an ideal protocol would install the desired 
pyran scaffolds in a time-efficient and one-pot procedure. 
Results and discussion 
Initially, 4-hydroxycoumarin (1a), 4-bromoacetophenone (2b), and 4-nitrobenzaldehyde 
(3f) were selected as model substrates for the reaction discovery and optimization 
(Scheme 1). When the model reaction was conducted under the visible light intensity 
(CFL, 20 W) in DMF at room temperature for 4h, the pyrano[3,2-c]chromen-5(4H)- 
one (4f) was obtained in 50% yield. In the absence of visible light intensity, no reaction 
was observed. 
The effect of solvent on the reaction was examined and ethanol is the best choice. When 
the model reaction was conducted in ethanol, 94% yield of (4f) was generated (Table 1). 
Other solvents such as dioxane, THF, DMF, DMSO, acetonitrile, methanol, toluene, and 
dichloromethane showed less reactivity providing (4f) in 42–78% yields. On varying the 
visible light intensity from 8 to 32 W, the best yield of (4f) was obtained in 22 W at room 
temperature. 
With the optimal condition for the synthesis of pyranocoumarins on hand, we studied 
the scope of this multicomponent process (Table 2). Various aromatic aldehydes and acet-
ophenones containing electron-donating and electron-withdrawing substituents at ortho, 
Scheme 1. Synthesis of pyranocoumarin derivatives under visible light condition at ambient temperature.  
Figure 1. A few natural products embedded with pyranocoumarin core skeleton.  
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Table 1. Optimization of visible light intensity and solvent screen for the synthesis of (4f). 
Entry Solvent Visible light intensity (W) Time (h) Yield (%)   
1 Dioxane  20  5.5 78  
2 THF  20  5 62  
3 DMF  20  4.0 50  
4 DMSO  20  5.5 42  
5 Acetonitrile  20  4 68  
6 Methanol  20  3.5 72  
7 Toluene  20  4.5 60  
8 CH2Cl2  20  4.0 48  
9 Ethanol  20  2.3 78  
10 Ethanol  22  3 94  
11 Ethanol  15  3.5 77  
12 Ethanol  8  4.2 43  
13 Ethanol  32  3 89 
Bold values represents the best results.   
Table 2. Synthesis of pyranocoumarin derivatives under visible light condition. 
No. R1 R2 R3 Product Time (h) Yield (%)   
1 H H 4a  3.0 89  
2 H 4-Br 4b  3.4 88  
3 H 4-Br 4c  3.3 87  
4 H 4-Br 4d  3.5 90  
5 H 4-Br 4e  3.3 92  
6 H 4-Br 4f  3.0 94  
7 H 4-Br 4g  3.2 96  
8 H 3-CH3, 4-OH 4h  3.5 92  
9 H 2-Cl, 4-Cl 4i  3.4 96   
(Continued) 
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meta, and para positions exhibited equal ease towards the product formation in excellent 
yields ranging from 87 to 96%. Heteroaromatic aldehydes such as imidazole and indole 
could also be accepted in the reaction. 5-Chloro-4-hydroxycoumarin was applied in the 
reaction instead of 4-hydroxycoumarin that successfully led to the corresponding pyrano 
[3,2-c]chromen-5(4H)-ones in high yields. 
On the basis of the above mentioned experimental results, a plausible reaction mech-
anism (Scheme 2) is proposed for the formation of pyranocoumarin derivatives.[30–34] 
Aldehydes (3a–j) undergo condensation with acetophenones (2a–i) to afford a chalcones. 
Michael addition of 4-hydroxycoumarins (1a–b) with chalcones produces the intermediate 
that on intramolecular cyclization gives the pyranocoumarins (4a–n). 
To know, whether the reaction takes place in a radical pathway or ionic pathway, the 
same model reaction was performed in the presence of hydroquinone which is a radical 
inhibitor.[35] The result indicated that only a trace amount of (4f) was produced. This 
experiment clearly demonstrated that the reaction proceeds in a radical pathway. 
Conclusion 
In conclusion, we have developed a one-pot methodology for the efficient synthesis of 
pyranocoumarin derivatives under visible light condition. Excellent yields, easy workup, 
ambient temperature, and short reaction time are the key advantages of this protocol. 
General information 
The melting points were determined using electric melting point apparatus with a 
calibrated thermometer. H1-NMR spectra were recorded using a Bruker/Jeol spectro-
photometer operating at 400 MHz and C13-NMR spectra were recorded at 100 MHz. 
The spectra were measured in CDCl3/DMSO-d6 relative to tetramethylsilane (TMS) 
(0.00 ppm). HRMS spectra were recorded using Waters Model: Synapt G2. The elemental 
Table 2. Continued. 
No. R1 R2 R3 Product Time (h) Yield (%)  
10 H 4-NO2 4j  3.2 90  
11 H 2-NO2 4k  3.3 90  
12 Cl 3-NO2 4l  3.2 91  
13 Cl 3-NO2 4m  3.0 89  
14 Cl 2-Cl, 4-Cl 4n  3.2 91   
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analyses were determined on Elemental Vario Micro Cube CHN Rapid Analyzer. CFL 
bulbs manufactured by Philips company were used for reaction conditions. 
Typical procedure for the synthesis of 2-(phenyl)-4-(phenyl)pyrano[3,2-c] 
chromen-5(4H)-one (4a) 
A 100 ml beaker was charged with 4-hydroxycoumarin (1a) (1 mmol), acetophenone (2a) 
(1 mmol) and benzaldehyde (3a) (1 mmol) in ethanol (10 mL). A glowing CFL bulb (22 W) 
was put inside the beaker but above the surface of the reaction mixture that was stirred 
under ambient condition for 3 h. The reaction progress and completion were monitored 
by TLC (Eluent: EtoAc and n-hexane). The organic layer was concentrated under reduce 
pressure. The residue was purified by recrystallization. 
2-(Phenyl)-4-(phenyl)pyrano[3,2-c]chromen-5(4H)-one (4a) 
A white solid, 313.3778 mg (89% yield). Mp 176–178 °C. 1H NMR (DMSO-d6 400 MHz): δ 
6.30 (s, 1H, CH) 7.07–7.84 (m, 15H, 14Ar-H & 1 Pyran-H) ppm. 13C NMR (CDCl3 100 MHz): 
δ 62.1, 110.7, 111.0, 116.7, 122.3, 123.3, 123.5, 124.1, 124.5, 125.1, 129.0, 129.2, 129.5, 130.1, 
132.6, 138.2, 144.0, 144.2, 144.5, 144.7, 155.7, 155.9 (2C), 168.9 ppm. HRMS: [M] ¼m/z 
353.1645; Anal. Calcd for C24H16O3: C, 81.80; H, 4.58; found: C, 81.60; H, 4.55%. 
Scheme 2. Proposed radical pathway for the formation of pyranocoumarin derivatives under visible 
light condition.  
SYNTHETIC COMMUNICATIONS® 813 
Associated content 
Supporting information 
1H NMR, 13C NMR, HRMS spectra, elemental analyses data, and experimental details for 
the compounds (4b-n). 
Funding 
This work is generously supported by the Department of Science and Technology-Science and 
Engineering Research Board (DST-SERB), New Delhi, India under the Fast Track Young Scientist 
Scheme (Grant No: SB/FT/CS-028/2013 dated: 09.06.2014, 24.09.2015, and 12.09.2016) in the form 
of major research project. 
References  
[1] Vekariya, R. H.; Patel, H. D. Synth. Commun. 2014, 44, 2756.  
[2] Dar, A. M.; Shamsuzzaman. Eur. Chem. Bull. 2015, 4, 249.  
[3] Kaur, C.; Dhiman, S.; Singh, H.; Kaur, M.; Bhagat, S.; Gupta, M.; Sharma, S.; Bedi, P. M. S. 
Asian J. Biochem. Pharm. Res. 2015, 7, 127.  
[4] Murray, R. D. H. Fortchemie 1991, 35, 1.  
[5] Makawana, J. A.; Patel, M. P.; Patel, R. G. Arch. Pharm. Chem. Life Sci. 2012, 345, 314.  
[6] Emmadi, N. R.; Atmakur, K.; Chityal, G. K.; Pombala, S. J.; Nanubolu, B. Bioorg. Med. Chem. 
Lett. 2012, 22, 7261.  
[7] Kumar, A.; Maurya, R. A.; Sharma, S. A.; Ahmad, P.; Singh, A. B.; Bhatia, G.; Srivastava, A. K. 
Bioorg. Med. Chem. Lett. 2009, 19, 6447.  
[8] Wang, H.; Lu, J.; Zhang, Z. Monatsh Chem. 2010, 141, 1107.  
[9] Mansoor, S. S.; Logaiya, K.; Aswin, K.; Sudhan, P. N. J. Taibah Univ. Sci. 2015, 9, 213. 
[10] Symeonidis, T.; Chamilos, M.; Litina, D. J. H.; Kallitsakis, M.; Litinas, K. E. Bioorg. Med. Chem. 
Lett. 2009, 19, 1139. 
[11] Coudert, P.; Couquelet, J. M.; Bastide, J.; Marion, Y.; Fialip, J. Ann. Pharm. Fr. 
1988, 46, 91. 
[12] Kaur, R.; Naaz, F.; Bedi, P. M. S.; Sharma, S.; Nepali, K.; Mehndiratta, S.; Gupta, M. K. Med. 
Chem. Res. 2015, 24, 3334. 
[13] Khoobi, M.; Alipour, M.; Sakhteman, A.; Nadri, H.; Moradi, A.; Emami, S.; Foroumadi, A.; 
Shafiee, A. Eur. J. Med. Chem. 2013, 68, 260. 
[14] Rafinejad, A.; Fallah-Tafti, A.; Tiwari, R.; Shirazi, A. N.; Mandal, D.; Shafiee, A.; Parang, K.; 
Foroumadi, A.; Akbarzadeh, T. DARU J. Pharm. Sci. 2012, 20, 1. 
[15] Gu, Y.; Jerome, F. Chem. Soc. Rev. 2013, 42, 9550. 
[16] Virdi, H. S.; Sharma, S.; Mehndiratta, S; Bedi, P. M. S.; Nepali, K. J. Enzyme Inhib. Med. Chem. 
2015, 30, 730. 
[17] Shaterian, H. R.; Honarmand, M. Synth. Commun. 2011, 41, 3573. 
[18] Sun, J.; Xia, E. Y.; Wu, Q.; Yan, C. G. ACS Comb. Sci. 2011, 13, 421. 
[19] Li, Z.; Gao, Y.; Jiao, Z.; Wu, N.; Wang, D. Z.; Yang, Z. Org. Lett. 2008, 10, 5163. 
[20] Beerappa, M.; Shivashankar, K. RSC Adv. 2015, 5, 30364. 
[21] Das, P.; Dutta, A.; Bhaumikb, A.; Mukhopadhyay, C. Green Chem. 2014, 16, 1426. 
[22] Khan, T.; Siddiqui, Z. N. New J. Chem. 2014, 38, 4847. 
[23] Guo, R. Y.; An, Z. M.; Mo, L. P.; Wang, R. Z.; Liu, H. X.; Wang, S. X.; Zhang, Z. H. ACS Comb. 
Sci. 2013, 15, 557. 
[24] Liu, Y.; Zhu, J.; Qian, J.; Jiang, B.; Xu, Z. J. Org. Chem. 2011, 76, 9096. 
[25] Khurana, J. M.; Vij, K. Synth. Commun. 2013, 14, 2294. 
[26] Saluja, P.; Aggarwal, K.; Khurana, J. M. Synth. Commun. 2013, 43, 3239. 
[27] Eshghi, H.; Damavandi, S.; Zohuri, G. H. Synth. React. Inorg. Met.-Org. Chem. 2011, 
41, 1067. 
814 A. N. NADAF AND K. SHIVASHANKAR 
[28] Islami, M. R.; Mosaddegh, E. Phosphorus Sulfur Silicon 2009, 184, 3134. 
[29] Wen, L. R.; Xie, H. Y.; Li, M. J. Heterocycl. Chem. 2009, 46, 954. 
[30] Haas, Y. Photochem. Photobiol. Sci. 2004, 3, 6. 
[31] Hoffmann, N. Chem. Rev. 2008, 108, 1052. 
[32] Tiwari, J.; Saquib, M.; Singh, S.; Tufail, F.; Singh, M.; Singh, J.; Singh, J. Green Chem. 2016, 18, 
3221. 
[33] Hari, D. P.; Konig, B. Org. Lett. 2011, 13, 3852. 
[34] Yadav, S.; Srivastava, M.; Rai, P.; Singh, J.; Tiwari, K. P.; Singh, J. New J. Chem. 2015, 39, 4556. 
[35] Zhang, M.; Fu, Q. Y.; Gao, G.; He, H. Y.; Zhang, Y.; Wu, Y. S.; Zhang, Z. H. ACS Sustainable 
Chem. Eng. 2017, 5, 6175.  
SYNTHETIC COMMUNICATIONS® 815 
